# Navignostics

Source: https://onco.cc/companies/navignostics/  
OnCo record `navignostics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Navignostics maps dozens of proteins at single-cell resolution across one tumour section, showing which cells sit next to which immune cells, to guide personalised treatment.

## Summary

Navignostics, a Zürich company, combines highly multiplexed tumour imaging with data analytics: spatial single-cell proteomic analysis of a single formalin-fixed section captures tumour and immune cell types and their interactions. Future of Cancer Care Today lists it for both molecular and immune profiling, physician-ordered through an early-access partner programme.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: Zürich, Switzerland
- Type: diagnostics
- Website: https://www.navignostics.com/

## Sources

- Official website: https://www.navignostics.com/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- technologies: [Imaging mass cytometry](https://onco.cc/technologies/imaging-mass-cytometry/), [Multiplex immunofluorescence](https://onco.cc/technologies/multiplex-immunofluorescence/), [Spatial transcriptomics](https://onco.cc/technologies/spatial-transcriptomics/)

---
JSON: https://onco.cc/api/v1/entities/navignostics.json